NCT00663949View on ClinicalTrials.gov

Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2008

Conditions
Diabetic Nephropathy
Interventions
DRUG

Captopril

25 mg captopril tablet q8h

DRUG

Captopril + Pentoxifylline

patients takes captopril tablets 25 mg q8h and pentoxifylline 400 mg q8h

Trial Locations (1)

0098

Shiraz University of Medical Sciences ,Nemazee and Faghihi Hospital, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT00663949 - Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy | Biotech Hunter | Biotech Hunter